False Claims Act Enforcement

Quantity

Back to Results

Recorded April 5, 2017 | On-Demand Webinar

Last year, the Supreme Court issued its opinion in Universal Health Services v. U.S. ex rel. Escobar, in which the Court affirmed the theory that violations of statutory and regulatory provisions can constitute actionable fraud under the False Claims Act (FCA). This webinar will explore different views on how this decision might affect FCA investigations and litigation in the coming years, including whether drug and device companies can expect more cases based on violations of provisions of the Federal Food, Drug & Cosmetic Act.

Jonathan M. Phillips, Associate Attorney, Gibson, Dunn & Crutcher LLP
Robert L. Vogel, Partner, Vogel, Slade & Goldstein LLP

IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you in your purchase.

Assign Members :

Members Assigned | Assign all contacts Unassign all contacts

Add New Contact

Assign	Full Name	Account Name	Email	Role

Total Records - Showing Page

Add New Contact

Discounts and special pricing for additional items will be applied once you add the item to your cart.